CSIMarket Company Name, Ticker, Suppliers, else..
 
Gri Bio Inc   (NASDAQ: GRI)
 
Price: $1.9200 $0.00 0.000%
Day's High: $1.9700000286102295 Week Perf: -2.04 %
Day's Low: $ 1.86 30 Day Perf: 39.13 %
Volume (M): 42,529 52 Wk High: $ 80.36
Volume (M$): $ 0 52 Wk Avg: $16.97
Open: $1.93 52 Wk Low: $1.36



 Market Capitalization (Millions $) 3
 Shares Outstanding (Millions) 2
 Employees 4
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -10
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) 0

Business Description


Gri Bio Inc is a biotechnology company that specializes in the research, development, and production of innovative biologic therapies and products. They aim to provide effective and safe solutions for various diseases and medical conditions. Gri Bio Inc utilizes advanced technologies and scientific expertise to develop treatments that address unmet medical needs. They have a strong focus on improving patient outcomes and advancing the field of biotechnology. Overall, Gri Bio Inc is dedicated to improving the quality of life for individuals through their innovative biologic therapies.


   Company Address: 2223 Avenida de la Playa La Jolla 92037 CA
   Company Phone Number: 400-1170   Stock Exchange / Ticker: NASDAQ GRI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ARVN   -1.5%    
BBIO   -5.53%    
DNTH   -4.05%    
MRVI   -9.37%    
NKTR   -3.13%    
TEVA   -2.38%    
• View Complete Report
   



Stocks on the Move

Gri Bio Inc Outperforms the Market with 3.35% Performance, Despite Cumulative Net Loss

Published Thu, Jul 4 2024 12:15 PM UTC

Gri Bio Inc, a biotechnology company focusing on Natural Killer T (NKT) cell modulators, has recently displayed promising performance despite facing certain challenges. This article aims to analyze the events surrounding Gri Bio Inc and its market performance, as well as discuss the company s net loss and return on assets in comparison to other healthcare sector companies.Gr...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book 0.34
PEG (TTM) -

Financial Strength Current
Quick Ratio 9.95
Working Capital Ratio 10.3
Leverage Ratio (MRQ) 0.11
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -6.51 $
Revenues (TTM) -
Cash Flow (TTM) 3.28 $
Cash 6.06 $
Book Value 5.7 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -2,414,750
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.